Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: emerging evi- dence for hematologists

The coronavirus disease (COVID-19), which is also known as acute respiratory syndrome coronavirus-2 (SARS-CoV2) is a transmissible disease, has phenotypes varying from asymptomatic to Acute Respiratory Distress Syndrome (ARDS) or multiple organ dysfunction syndrome (MODS) and ultimately death in cer...

Full description

Autores:
Tipo de recurso:
Article of investigation
Fecha de publicación:
2020
Institución:
Universidad de Bogotá Jorge Tadeo Lozano
Repositorio:
Expeditio: repositorio UTadeo
Idioma:
eng
OAI Identifier:
oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/15601
Acceso en línea:
https://doi.org/10.1016/j.sjbs.2020.11.006
http://hdl.handle.net/20.500.12010/15601
Palabra clave:
COVID-19
SARS-CoV-2
Thrombosis
Anticoagulant therapy
Disseminated intravascular coagulation (DIC)
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Rights
License
Abierto (Texto Completo)